| |
| |
|
| Insider
Information: |
Tang Capital Partners Lp |
| Relationship: |
10% Owner |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
15 |
|
| Direct
Shares |
123,746 |
|
|
Indirect Shares
|
35,438,120 |
|
|
| Direct
Value |
$20,947 |
|
|
|
Indirect Value
|
$66,544,358 |
|
|
| Total
Shares |
35,561,866 |
|
|
| Total
Value |
$66,565,304 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
1
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
11
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -4.3%
|
-74.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APVO |
Aptevo Therapeutics Inc. |
10% Owner |
– – • |
2020-11-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
323,325 |
|
% |
|
| APVO |
Aptevo Therapeutics Inc. |
10% Owner |
– – • |
2020-11-04 |
4 |
B |
$10.63 |
$9,137,026 |
I/I |
636,675 |
960,000 |
1.5 |
% |
|
| APVO |
Aptevo Therapeutics Inc. |
10% Owner |
– – • |
2020-11-05 |
4 |
B |
$14.22 |
$11,750,307 |
I/I |
625,723 |
1,585,723 |
1.5 |
% |
|
| APVO |
Aptevo Therapeutics Inc. |
10% Owner |
– – • |
2020-11-06 |
4 |
B |
$20.63 |
$3,961,898 |
I/I |
174,277 |
1,760,000 |
1.5 |
% |
|
| APVO |
Aptevo Therapeutics Inc. |
Exit Filing |
– – – |
2021-11-23 |
4 |
S |
$9.60 |
$10,368,236 |
I/I |
(921,336) |
0 |
0 |
% |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2008-09-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,310,000) |
0 |
0 |
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2008-10-10 |
4 |
B |
$0.24 |
$10,602 |
I/I |
45,000 |
5,355,000 |
1.5 |
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2008-10-13 |
4 |
B |
$0.24 |
$6,000 |
I/I |
25,000 |
5,380,000 |
1.5 |
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2008-10-20 |
4 |
B |
$0.24 |
$4,080 |
I/I |
17,000 |
5,397,000 |
1.42 |
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2008-10-21 |
4 |
B |
$0.24 |
$2,400 |
I/I |
10,000 |
5,407,000 |
1.42 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
– – • |
2017-02-23 |
4 |
B |
$4.34 |
$582,079 |
I/I |
134,200 |
559,900 |
1.5 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
– – • |
2017-02-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
425,700 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2007-06-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,291,335 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-04-22 |
4 |
B |
$1.00 |
$685,604 |
I/I |
685,612 |
4,689,997 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-04-23 |
4 |
B |
$1.00 |
$300 |
I/I |
300 |
4,690,297 |
1.42 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-04-24 |
4 |
B |
$1.00 |
$10,160 |
I/I |
10,160 |
4,700,457 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-04-25 |
4 |
B |
$1.00 |
$5,236 |
I/I |
5,236 |
4,705,693 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-09-30 |
4 |
B |
$0.97 |
$627,900 |
I/I |
650,000 |
5,355,693 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-10-10 |
4 |
B |
$0.74 |
$647,019 |
I/I |
870,000 |
6,225,693 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-10-31 |
4 |
B |
$0.61 |
$204,067 |
I/I |
336,300 |
6,561,993 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-11-13 |
4 |
B |
$0.48 |
$404,725 |
I/I |
841,032 |
7,403,025 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-12-18 |
4 |
B |
$0.48 |
$200,673 |
I/I |
415,300 |
7,818,325 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2008-12-31 |
4 |
B |
$0.42 |
$72,625 |
I/I |
175,000 |
7,993,325 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2009-10-19 |
4 |
B |
$0.88 |
$2,149,999 |
I/I |
2,443,181 |
10,436,506 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • • |
2010-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
95,891 |
138,841 |
0 |
- |
|
176 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
